The combination of deoxynivalenol and zearalenone at permitted feed concentrations causes serious physiological effects in young pigs.
- Author:
Feng CHEN
1
;
Yulin MA
;
Chunyi XUE
;
Jingyun MA
;
Qingmei XIE
;
Genhu WANG
;
Yingzuo BI
;
Yongchang CAO
Author Information
- Publication Type:Original Article ; Controlled Clinical Trial ; Research Support, Non-U.S. Gov't
- Keywords: deoxynivalenol; mycotoxins; physiological effects; pigs; zearalenone
- MeSH: Animal Feed/*analysis; Animal Nutritional Physiological Phenomena; Animals; Diet/veterinary; Drug Therapy, Combination; Female; Swine; Swine Diseases/blood/*chemically induced/*physiopathology; Trichothecenes/*administration & dosage/*adverse effects/pharmacology; Zearalenone/*administration & dosage/*adverse effects/pharmacology
- From:Journal of Veterinary Science 2008;9(1):39-44
- CountryRepublic of Korea
- Language:English
- Abstract: This study was to investigate the effects of the combination of deoxynivalenol (DON) and zearalenone (ZON) on pigs. Twenty-four weaning piglets were divided into a control group fed a diet free of mycotoxins and a toxin group fed a diet containing 1 mg/kg DON and 250 microgram/kg ZON. The results showed that supplementation of DON and ZON in diets had extensive effects on pigs. More specifically, DON and ZON caused levels of total protein, albumin, and globulin in sera to decrease (p < 0.05) by 14.5%, 6.5% and 11.3%, respectively, and at the same time increased (p < 0.05) the serum enzyme activities of gamma-glutamyltransferase, aspartate aminotransferase and alanine aminotransferase by 72.0%, 32.6% and 36.6%, respectively. In addition, DON and ZON decreased (p < 0.05) the level of anticlassical swine fever antibody titers by 14.8%. Real-time PCR showed that DON and ZON caused the mRNA expression levels of IFN-gamma, TNF-alpha, IL-2, to decrease (p < 0.05) by 36.0%, 29.0% and 35.4%, respectively. Histopathological studies demonstrated that DON and ZON caused abnormalities in the liver, spleen, lymph nodes, uterus, and kidney. The concentrations of DON and ZON used in this study are in line with the published critical values permitted by BML. Our study clearly put the standard and adequacy of safety measures for these toxins into question. The authors suggest that with the increasing availability of cellular and molecular technologies, it is time to revisit the safety standards for toxins in feeds so as to make feeds safer, providing consumers with safer products.
